TerraPower Isotopes, part of a nuclear power company founded by Bill Gates, plans a $450 million plant in the Bellwether ...

To produce actinium-227, the isotope used for an FDA-approved cancer treatment, the first step is to bombard targets of the ...

The blast is what people imagine. A sudden flash, a rising cloud, the moment when history splits into “before” and “after”.

Oklo (OKLO) stock climbed 2.35% after receiving its first NRC materials license, enabling isotope processing while advancing Aurora reactor development.

The Bill Gates-backed company is planning a 250,000-square-foot Bellwether District facility to produce actinium-225, a rare isotope used in nuclear medicine.

A massive South Philadelphia development project has scored a $450 million investment from Bill Gates' nuclear science ...

A Rhode Island start-up is working to recycle spent nuclear fuel into long-lasting power systems for the military ...

Shares of Oklo Inc. rose on Tuesday after the nuclear start-up secured its first license from the US Nuclear Regulatory Commission (NRC), marking a key step toward commercial acti ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of ...

To call this book strange would be an understatement. Katherine Dunn’s 1989 literary horror masterpiece “Geek Love” is utter ...

The Section aims to strengthen the capacities of Member States in producing radioisotope products for the management of cancer and other chronic diseases and to develop and implement radiation ...